Amgen was delivered a nasty surprise about its superblockbuster Enbrel this week when a new study found that a cocktail of generics already on the market was as effective at treating rheumatoid arthritis.
AbbVie's rheumatoid arthritis drug Humira did exactly what the new company needed it to do in the first quarter. It returned significantly higher sales and allowed Abbvie to report better than expected earnings in its first earnings report as a stand-alone company.
Pfizer has big expectations for its oral rheumatoid arthritis treatment Xeljanz--about $3 billion worth. But those expectations were struck a serious blow when European Medicines Agency regulators Thursday turned it down for approval.
While the FDA continues its slow-motion release of new guidelines for producing biosimilars in the U.S., India's Cipla has stepped up with a knockoff of the rheumatoid arthritis blockbuster Enbrel, which it will sell in the subcontinent at a 30% discount.
Should taxpayers enjoy lower drug prices if federal money backed development? At least one U.S. senator thinks so, now that Pfizer has slapped a $2,000-per-month sticker price on the new rheumatoid arthritis drug Xeljanz.
Crescendo Bioscience unveiled an iPhone app as a new resource for patients using its rheumatoid arthritis molecular diagnostic test.
Ignyta will work with Leiden University Medical Center on new biomarker research involving patients with early synovitis and rheumatoid arthritis.
San Diego's Inova Diagnostics licensed some new technology developed in The Netherlands it hopes to apply to a rheumatoid arthritis diagnostic.
Harris Interactive has been digging into physicians' response to drug brands, therapeutic area by therapeutic area, racking up more evidence for an emotional variable in the doctor-drug trust equation.
With a $28 million Series D venture round now in place, Crescendo Bioscience is focusing on boosting commercialization of its rheumatoid arthritis blood test--a novel diagnostic that gives a precise snapshot of the disease's activity levels by measuring multiple biomarkers.